Stock- Based Compensation (Tables)

12 Months Ended

Jun. 30, 2025

Share-Based Payment Arrangement [Abstract]

Summary of the Information regarding Grants

The following table sets forth information regarding the grants:

Date of grant	November 21, 2024			January 29, 2025			February 5, 2025
Options granted		237,695			465,889			57,009
Exercise price	$	11.04		$	12.50		$	12.36
Vesting period (years)		5.00			5.00			5.00
Expiration date	November 21, 2034			January 29, 2035			February 5, 2035
Expected Volatility(1)		27.90	%		27.87	%		27.87	%
Expected term (years)(2)		6.50			6.50			6.50
Expected dividend yield(3)		0.00	%		0.00	%		0.00	%
Forfeiture rate		0.00	%		0.00	%		0.00	%
Risk free rate of return(4)		4.36	%		4.44	%		4.33	%
Fair value per option	$	4.24		$	4.82		$	4.73

(1)Expected volatility is based on the standard deviation of the historical volatility of the daily adjusted closing price of a group of peers' shares

(2)Expected term represents the period of time that the option is expected to be outstanding, determined using the "Simplified Method"

(3)Expected dividend yield is determined based on management's expectations regarding issuing dividends in the foreseeable future

(4)The risk-free rate of return is based on the U.S. Treasury yield curve in effect at the time of grant for a period equivalent to the expected term of the option

Schedule of the Stock Option Activities

The following table represents stock option activities for the period indicated:

	Year Ended June 30, 2025
	Shares		Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Term (years)		Aggregate Intrinsic Value
							(In thousands)
Balance at beginning of period		—	$	—		—	$	—
Granted		760,593		12.03		9.77		—
Exercised		—		—		—		—
Vested		—		—		—		—
Forfeited or expired		—		—		—		—
Balance at end of period		760,593	$	12.03		9.77	$	1,116
Exercisable at end of period		—	$	—		—	$	—

Schedule of the Restricted Stock Award Activities

The following table represents information regarding restricted stock award activities for the periods indicated:

	Year Ended June 30, 2025
	Number of Shares		Weighted- Average Grant Date Fair Value Per Share
Balance at beginning of period		—	$	—
Granted		304,231		12.03
Vested		—		—
Forfeited		—		—
Balance at end of period		304,231	$	12.03

Summary of Compensation Expense and Income Tax Benefit Recognized

The following table represents the compensation expense and income tax benefit recognized for stock options and restricted stock awards for the period indicated:

	Year Ended June 30, 2025
	(In thousands)
Stock-based compensation expense
Stock options	$	327
Restricted stock awards		340
Total stock-based compensation expense	$	667
Related tax benefits recognized in earnings	$	188

Summary of Total Compensation Cost Related to Non-Vested Awards Not Yet Recognized and the Weighted Average Period

The following table sets forth the total compensation cost related to non-vested awards not yet recognized and the weighted average period (in years) over which it is expected to be recognized as of June 30, 2025:

	Amount		Weighted Average Period (years)
	(In thousands)
Stock options	$	3,196		4.53
Restricted stock awards		3,321		4.53
Total	$	6,517

Summary of Shares Held by the ESOP

Shares held by the ESOP were as follows:

	June 30, 2025		June 30, 2024
	(In thousands)
Allocated to participants		76,064		38,032
Committed to be allocated		19,016		19,016
Unallocated		665,554		703,586
Total ESOP shares		760,634		760,634
Fair value of unearned shares	$	8,985	$	6,508